Mitchell Davis

6.5k citations
41 papers · 2.5k · 2 hit papers · h-index 17

Impact in

  • Hepatology top 0.2%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment

Papers in

    • Hepatitis C virus research 25
    • Hepatitis B Virus Studies 13
    • Liver Disease Diagnosis and Treatment 12

Mitchell Davis

38 papers receiving 2.4k citations

Mitchell Davis's Hit Papers

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial 2010 · 515 citations
5150+5+11Years since publication250500750

Peers

Mitchell Davis
Comparison fields: 5 of 97
  • Hepatology 2.2k
  • Epidemiology 2.0k
  • Otorhinolaryngology 186
  • Infectious Diseases 422
  • Immunology and Allergy 103
Replace Bach‐Nga Pham with:
Bach‐Nga Pham France
G. S. A. McDonald Ireland
Weibin Bao United States
Neena Sood India
Andrew Campbell United States
Greg Galler United States
John Boitnott United States
Wolf Peter Hofmann Germany
Jean‐Paul Viard France
Mathew Simcock Switzerland
Mitchell Davis relative to Bach‐Nga Pham France Bach‐Nga Pham's profile →
Citations per field
00.5×10×20×26.6×
Bach‐Nga Pham · 1×
Citations per year

Countries citing papers authored by Mitchell Davis

Since Specialization
Citations

This map shows the geographic impact of Mitchell Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Davis more than expected).

Fields of papers citing papers by Mitchell Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Davis. The network helps show where Mitchell Davis may publish in the future.

Co-authors

The 25 scholars most cited alongside Mitchell Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchell Davis Line = papers co-authored together Mitchell Davis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
Hit paper breakdown →
2009889
2
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Hit paper breakdown →
2010515
3 1997236
4 2013227
5 2016143
6 201582
7 200966
8 201760
9 201551
10 201231
11 200831
12 201623
13 201423
14 201222
15 201021
16 201317
17 200316
18 19738
19 20117
20 20136

About Mitchell Davis

Mitchell Davis is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Genetics and Genetics, having authored 41 papers that have together received 2.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (13 papers), Liver Disease Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (5 papers), HIV/AIDS drug development and treatment (5 papers), Platelet Disorders and Treatments (3 papers), Reconstructive Facial Surgery Techniques (2 papers) and Surgical Sutures and Adhesives (2 papers). The work is most often cited by research in Hepatology (2.2k citations), Epidemiology (2.0k citations), Otorhinolaryngology (186 citations), Infectious Diseases (422 citations) and Immunology and Allergy (103 citations). Mitchell Davis has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Eric Lawitz, Jonathan McCone, Joseph Galati, Eugene R. Schiff, Kenneth Koury, Lisa D. Pedicone, Clifford A. Brass, Janice K. Albrecht, John G. McHutchison and Mark Sulkowski. Their work appears in journals such as Journal of Hepatology, Hepatology, The Lancet, Gastroenterology and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact